SCHEMBL15070211

SCHEMBL15070211

O=C(O)c1cn(-c2ccncc2)nc1-c1cccnc1

nearest known ligand 0.71

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.71
L3MBTL1 Q9Y468 3/20 0.71
SMN1; SMN2 Q16637 2/20 0.71
KDM4E B2RXH2 2/20 0.71
HSD17B10 Q99714 2/20 0.71
HPGD P15428 1/20 0.71
MAPK1 P28482 1/20 0.66
NPC1 O15118 1/20 0.62
RAB9A P51151 1/20 0.62
HTT P42858 2/20 0.60
GAA P10253 1/20 0.55
GSK3A P49840 1/20 0.52
GSK3B P49841 1/20 0.52
TP53 P04637 1/20 0.52
ATM Q13315 1/20 0.51
LMNA P02545 1/20 0.51
KMT2A Q03164 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6677466 0.93 MAPK1 (0.75) ALDH1A1L3MBTL1SMN1; SMN2KDM4EHSD17B10
SCHEMBL15070209 0.90 MAPK1 (0.67) ALDH1A1L3MBTL1SMN1; SMN2KDM4EHSD17B10
SCHEMBL15076914 0.89 ALDH1A1 (0.89) ALDH1A1L3MBTL1SMN1; SMN2KDM4EHSD17B10
SCHEMBL15076916 0.86 ALDH1A1 (0.80) ALDH1A1L3MBTL1SMN1; SMN2KDM4EHSD17B10
SCHEMBL15070383 0.86 ALDH1A1 (0.88) ALDH1A1L3MBTL1SMN1; SMN2KDM4EHSD17B10
SCHEMBL6681044 0.83 ALDH1A1 (1.00) ALDH1A1L3MBTL1SMN1; SMN2KDM4EHSD17B10
SCHEMBL15072200 0.82 ALDH1A1 (0.67) ALDH1A1L3MBTL1SMN1; SMN2KDM4EHSD17B10
SCHEMBL15072193 0.81 ALDH1A1 (0.74) ALDH1A1L3MBTL1SMN1; SMN2KDM4EHSD17B10
SCHEMBL15072201 0.81 ALDH1A1 (0.66) ALDH1A1L3MBTL1SMN1; SMN2KDM4EHSD17B10
SCHEMBL15072197 0.81 ALDH1A1 (0.66) ALDH1A1L3MBTL1SMN1; SMN2KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130165464-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-06-27 US disclosed
US-20130165464-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-06-27 US disclosed
US-20130165483-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-06-27 US disclosed
US-20130165483-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165483-A1 HETEROARYLS AND USES THEREOF PIK3R5, PIK3R4, PIK3C2B ALDH1A1 3473/4885L3MBTL1 196/4885SMN1; SMN2 3990/4885
US-20130165464-A1 HETEROARYLS AND USES THEREOF PIK3C2B, PI4KB, PIK3R4 ALDH1A1 2884/4885L3MBTL1 866/4885SMN1; SMN2 3783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.